Tori Rodriguez

Mehdi Jorfi, PhD, discusses the opportunities to optimize the development and application of neurotechnologies for AD.

Although significant research has been done into the ongoing health and respiratory effects of the 9/11 World Trade Center attack, more studies are needed.

Aduhelm, a monoclonal antibody that targets amyloid-beta, is covered under Medicare for beneficiaries enrolled in clinical trials.

David Howell, PhD and Heather Sesma, PhD provide insight into the specific sequelae of concussion in youth and risk for subsequent mental health issues.

The overwhelming demands on health care resources in treating patients with COVID-19 and the heterogeneity in illness presentation highlights the need for strategies to predict which individuals are at risk for greater symptom severity.

Tori Rodriguez, MA, LPC, discusses chronic pain among patients with Parkinson disease and the breakdown of disease subtypes, classification, and pathophysiology.

A substantial body of research points to a multifaceted link between depression and cardiovascular disease, with rates of depression being 3 times higher in patients with coronary artery disease compared to the general population

Many older persons may have subthreshold depression, defined in the DSM-5 as depressed mood with at least 1 symptom of MDD and the presence of “clinically significant distress or deficit lasting at least 2 weeks.”

Dr Jha provided discussion regarding the use of anti-inflammatory therapies for depression.

Delirium is highly prevalent in critical care, especially among elderly patients and individuals with dementia. Although rates vary widely across studies, findings suggest delirium affects more than 15% of hospitalized patients. For additional discussion regarding this topic, Neurology Advisor interviewed Leopoldo Pozuelo, MD, MBA, FACP, FACLP, clinical vice chair of psychiatry and psychology at the Cleveland Clinic in Ohio.